Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Millennium Pharmaceuticals Ltd.

Division of Takeda Pharmaceutical Co. Ltd.
www.cam-com.com

Latest From Millennium Pharmaceuticals Ltd.

Teva Beats Janssen On Canadian Bortezomib Compensation

Teva is eligible for compensation due to having been kept off the Canadian bortezomib market by Janssen suing for infringement of two patents that were subsequently found to be obvious.

Intellectual Property Canada

Mersana Back On Track After Speedy Changes To ADC Program

Following a clinical hold for its lead product, Mersana explains how it re-engineered the program and how it is developing its ADC platform further.

Clinical Trials Research and Development Strategies

Appointments: Amgen, Sirnaomics, Pandion, Purdue, Cardurion, OncoSec Make Senior Hires

Senior executives are to depart Gilead Sciences, Bristol-Myers Squibb and Amgen, while C-suite and board hires have been reported at Sirnaomics, Pandion, Purdue Pharma, Cardurion and OncoSec.

Appointments Commercial

Appointments: New CEOs For Lundbeck, Voyager & Neos, CSOs For iTeos & Tilos

Deborah Dunsire’s appointment to lead Lundbeck tops this week’s list of new hires; Astellas, Orchard Therapeutics, Voyager Therapeutics, iTeos Therapeutics, Cevec Pharmaceuticals, Sangamo Therapeutics, Cedilla Therapeutics, Tilos Therepautics and Neos Therapeutics have also appointed new executives and directors.

Appointments Leadership
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Cambridge Combinatorial Ltd.
  • Cambridge Discovery Chemistry
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Takeda Pharmaceutical Co. Ltd.
  • Senior Management
  • Deborah Dunsire, MD, Pres. & CEO
    Joseph Bolen, PhD, CSO
    Daniel Curran, MD, VP, Bus. & Corp. Dev.
  • Contact Info
  • Millennium Pharmaceuticals Ltd.
    Phone: (44) 12237224
    The Merrifield Centre
    Rosemary Lane
    Cambridge, CB1 3LQ
    UK
UsernamePublicRestriction

Register